fda 510k semaglutide immunoassay The FDA submission process: 510K vs PMA. What's the difference? Novo Nordisk's semaglutide gains ground

Activation of peroxisome proliferator-activated receptor gamma is crucial for antitumoral effects of 6-iodolactone

This patient took Wegovy for 6 months after being prescribed the drug by her doctor

Insulin Resistance Insulin resistance can be a root cause underlying metabolic syndrome and virtually every chronic disease

Effects of GLP-1 receptor agonists on neurological complications of diabetes

It is still too early to assess the promise of these cell therapy assets relative to semaglutide and tirzepatide

But with so many new options, including dual and triple agonists, its normal to have questions about how they work and whether theyre right for you